BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37848823)

  • 1. DNA methylation-regulated LINC02587 inhibits ferroptosis and promotes the progression of glioma cells through the CoQ-FSP1 pathway.
    Wang Z; Cui Y; Wang F; Xu L; Yan Y; Tong X; Yan H
    BMC Cancer; 2023 Oct; 23(1):989. PubMed ID: 37848823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetically silenced lncRNA SNAI3-AS1 promotes ferroptosis in glioma via perturbing the m
    Zheng J; Zhang Q; Zhao Z; Qiu Y; Zhou Y; Wu Z; Jiang C; Wang X; Jiang X
    J Exp Clin Cancer Res; 2023 May; 42(1):127. PubMed ID: 37202791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [SRSF2 promotes glioblastoma cell proliferation by inducing alternative splicing of FSP1 and inhibiting ferroptosis].
    Hua D; Zhou XX; Wang Q; Sun CY; Shi CJ; Luo WJ; Jiang ZD; Yu SZ
    Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):430-438. PubMed ID: 38678322
    [No Abstract]   [Full Text] [Related]  

  • 4. Ferroptosis-Related Long Noncoding RNAs Have Excellent Predictive Ability for Multiomic Characteristics of Bladder Cancer.
    Liu J; Cui J; Zhao S; Wu M; Wang J; Zhang Y; Jin B; Wang J
    Oxid Med Cell Longev; 2022; 2022():9316847. PubMed ID: 36071865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA BCYRN1 inhibits glioma tumorigenesis by competitively binding with miR-619-5p to regulate CUEDC2 expression and the PTEN/AKT/p21 pathway.
    Mu M; Niu W; Zhang X; Hu S; Niu C
    Oncogene; 2020 Nov; 39(45):6879-6892. PubMed ID: 32978519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of SLC39A14 inhibits glioma progression by promoting erastin-induced ferroptosis SLC39A14 knockdown inhibits glioma progression.
    Zhang Y; Wu X; Zhu J; Lu R; Ouyang Y
    BMC Cancer; 2023 Nov; 23(1):1120. PubMed ID: 37978473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fear stress promotes glioma progression through inhibition of ferroptosis by enhancing FSP1 stability.
    Bu C; Hu S; Yu J; Li N; Gu J; Sheng Z; Yan Z; Bu X
    Clin Transl Oncol; 2023 May; 25(5):1378-1388. PubMed ID: 36484954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis.
    Bersuker K; Hendricks JM; Li Z; Magtanong L; Ford B; Tang PH; Roberts MA; Tong B; Maimone TJ; Zoncu R; Bassik MC; Nomura DK; Dixon SJ; Olzmann JA
    Nature; 2019 Nov; 575(7784):688-692. PubMed ID: 31634900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA LPP-AS2 promotes glioma tumorigenesis via miR-7-5p/EGFR/PI3K/AKT/c-MYC feedback loop.
    Zhang X; Niu W; Mu M; Hu S; Niu C
    J Exp Clin Cancer Res; 2020 Sep; 39(1):196. PubMed ID: 32962742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of CoQ shifts ferroptosis dependence from GPX4 to FSP1 in acquired radioresistance.
    Lin X; Zhang Q; Li Q; Deng J; Shen S; Tang M; Ye X; Ji C; Yang Y; Chen Y; Zeng L; Zhao J; Kouwenhoven MBN; Lucero-Prisno DE; Huang J; Li Y; Zhang B; Hu J
    Drug Resist Updat; 2024 Mar; 73():101032. PubMed ID: 38198846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA ATXN8OS promotes ferroptosis and inhibits the temozolomide-resistance of gliomas through the ADAR/GLS2 pathway.
    Luo J; Bai R; Liu Y; Bi H; Shi X; Qu C
    Brain Res Bull; 2022 Aug; 186():27-37. PubMed ID: 35460867
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Emmanuel N; Li H; Chen J; Zhang Y
    Oncotarget; 2022 Oct; 13():1136-1139. PubMed ID: 36264074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers.
    Koppula P; Lei G; Zhang Y; Yan Y; Mao C; Kondiparthi L; Shi J; Liu X; Horbath A; Das M; Li W; Poyurovsky MV; Olszewski K; Gan B
    Nat Commun; 2022 Apr; 13(1):2206. PubMed ID: 35459868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA GAS5, by up-regulating PRC2 and targeting the promoter methylation of miR-424, suppresses multiple malignant phenotypes of glioma.
    Jin C; Zhao J; Zhang ZP; Wu M; Li J; Xiao GL; Liu B; Liao YX; Liu JP
    J Neurooncol; 2020 Jul; 148(3):529-543. PubMed ID: 32472311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel lncRNA ARST represses glioma progression by inhibiting ALDOA-mediated actin cytoskeleton integrity.
    Sun J; He D; Fu Y; Zhang R; Guo H; Wang Z; Wang Y; Gao T; Wei Y; Guo Y; Pang Q; Liu Q
    J Exp Clin Cancer Res; 2021 Jun; 40(1):187. PubMed ID: 34099027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetically regulated lncRNAs dissect the intratumoural heterogeneity and facilitate immune evasion of glioblastomas.
    Xu D; Cao M; Wang B; Bi X; Zhang H; Wu D; Zhang C; Xu J; Xu Z; Zheng D; Chen L; Li P; Wang H; Liu Y; Jiang H; Li K
    Theranostics; 2023; 13(5):1490-1505. PubMed ID: 37056564
    [No Abstract]   [Full Text] [Related]  

  • 17. Data mining of bulk and single-cell RNA sequencing introduces OBI1-AS1 as an astrocyte marker with possible role in glioma recurrence and progression.
    Mamivand A; Bayat S; Maghrouni A; Shabani S; Khoshnevisan A; Saffar H; Tabrizi M
    Clin Epigenetics; 2022 Mar; 14(1):35. PubMed ID: 35260196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4-acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA.
    Zheng X; Wang Q; Zhou Y; Zhang D; Geng Y; Hu W; Wu C; Shi Y; Jiang J
    Cancer Commun (Lond); 2022 Dec; 42(12):1347-1366. PubMed ID: 36209353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing lncRNA SLC16A1-AS1 Induced Ferroptosis in Renal Cell Carcinoma Through miR-143-3p/SLC7A11 Signaling.
    Li YZ; Zhu HC; Du Y; Zhao HC; Wang L
    Technol Cancer Res Treat; 2022; 21():15330338221077803. PubMed ID: 35167383
    [No Abstract]   [Full Text] [Related]  

  • 20. Super-enhancer-associated TMEM44-AS1 aggravated glioma progression by forming a positive feedback loop with Myc.
    Bian E; Chen X; Cheng L; Cheng M; Chen Z; Yue X; Zhang Z; Chen J; Sun L; Huang K; Huang C; Fang Z; Zhao B; Li J
    J Exp Clin Cancer Res; 2021 Oct; 40(1):337. PubMed ID: 34696771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.